The South Korea-US Free Trade Agreement, which was signed on June 30 2007, includes an approval-patent linkage system which would have a significant impact on the Korean pharmaceutical industry. Under the approval-patent linkage system, a patent owner who has obtained product approval on a medicine may register his or her patent on the Medicine Patent List, the so-called Green List, so that his or her patent may be eligible for protection measures provided under the Agreement.
